Woods v. Takeda Pharmaceuticals North America Inc et al | Search

Accessibility help Skip to navigation Skip to content Skip to footer

Showing results for Woods v. Takeda Pharmaceuticals North America Inc et al

Sort by

Viewing results 1‒17 of 17

Smart MoneyStephen Foley
Hedge fund stockpicking tests investors
...Funds may have sold out of Valeant, Apple et al before the rot set in....
January 4, 2016
Tech blogRichard Waters
Google to face US wiretapping claims in StreetView case
...The latest case, Google v Joffe et al, involves a class action suit stemming from the company’s illicit collection of snippets of information from WiFi networks in homes that its StreetView cars were passing...
June 30, 2014
FT Live
Future of Asset Management North America
New models for the next age of fund management
Wednesday, 25 SeptemberNew York, NY, USA
Life & Arts
Backstage with a pre-teen
...While the black taffeta evening gowns and sturdy looking peacoats on Karlie Kloss et al shouted winter, the models’ peachy complexions were all spring – try Bobbi Brown’s Sheer Color Cheek Tint in Sheer...
March 1, 2013
Tech blogChris Nuttall
How Apple changed the publishing industry
...United States v Apple, Inc et al is more than a US Justice department antitrust action against publishers allegedly colluding on ebook prices....
April 11, 2012
Christopher CaldwellMedia
Pull the plug on TV’s push to dodge decency standards
...The case (now called FCC v. Fox Television Stations et al) was appealed to the US Supreme Court, where it was debated on Tuesday....
January 13, 2012
Mergers & Acquisitions
Buy-out groups reshape India’s M&A landscape
...Indian skills have developed strongly in technology and services, and opportunities arise in a wide sectoral spread including healthcare, telecoms, engineering and pharmaceuticals....
July 19, 2010
FT Live
Innovative Lawyers Awards North America
Celebrating innovations from both law firms and in-house teams in the region
Monday, 9 DecemberGotham Hall, Broadway, New York, NY, USA
US & Canadian companies
Viewpoint: Lessons to be learnt
...Had the central bank allowed the failure of Long Term Capital Management to run its course, Lehman, Bear Stearns, et al would still be here....
September 9, 2009
Life & Arts
Padded sell
...Gardeners in North America came up with their own versions of vertical gardens faster than in the UK but now London has the world’s biggest – a 600 sq metre monster at a shopping centre....
August 1, 2009
Fund management
Turning point for US mutual fund fees
...The case, Gallus et al. v....
May 31, 2009
Asia-Pacific equities
Asia-Pacific markets extend the rally
...Takeda Pharmaceutical rose by 3.7 per cent to Y3,650, although news that regulators had approved its diabetes drug for new applications came after the market close....
March 24, 2009
Asia-Pacific equities
Financial stocks lead Asian dip
...Takeda Pharmaceutical, Japan’s biggest drugs company, fell 13.1 per cent to Y3,320 after US regulators said they needed more information to approve or reject a new medicine, raising the prospects of lengthy...
March 9, 2009
Mergers & Acquisitions
Asian shares lower after choppy session
...With reporting by Andrew Wood in Hong Kong...
November 17, 2008
FT AlphavilleIPOs
See you in court, Countrywide edition
...Freddie Mac and Fannie Mae (on behalf of) suing in NYC and DC: Bassman v. Syron, et. al (FRE) Agnes v....
August 13, 2008
Central banks
Asian shares boosted by interest rate cuts
...Takeda Pharmaceutical dropped 5.5 per cent to a 52-week low of Y4,660 as the company said cuts in the price of drugs would affect domestic sales....
October 9, 2008
Oil
Asian markets mixed as oil retreats
...Takeda Pharmaceutical gained 2.8 per cent to Y5,910 and Astellas Pharma rose by 1.9 per cent to Y4,340. Oil companies gave up some of their gains made earlier this week when the price of oil surged....
May 23, 2008
FT Live
Infrastructure Investment in Latin America and the Caribbean
Identifying opportunities for investors and asset managers
Wednesday, 12 June237 Park Avenue, New York, NY, USA
Semiconductors
Japan property groups hit by downgrades
...Takeda Pharmaceutical, one of Japan’s largest drug companies, said it would buy US rival Millennium Pharmaceuticals in a deal worth $8.8bn. Takeda shares fell 2.5 per cent to Y5,410....
April 10, 2008
European banks
Tighter monetary policy hits Asian shares
...Elsewhere, Takeda Pharmaceutical and other drugmakers lost ground on newspaper reports that the government plans to cut medical costs by more than 1 per cent next fiscal year....
December 17, 2007

Previous pagePage 1 of 1Next page